73. 有關於 phosphodiesterase-4 (PDE4) inhibitors 的藥物用於 COPD 治療,下列何者為非:
(A) By its mechanism, PDE4 inhibitors decrease airway inflammation and have direct bronchodilator activity.
(B) PDE4 inhibitors has been approved for patients with chronic bronchitis and a history of exacerbation
(C) Guidelines recommend that PDE4 inhibitors be used in combination with a long-acting bronchodilators
(D) Monitoring weight during treatment is warranted.
私人筆記 (共 1 筆)
未解鎖
詳解: (A) no direct br...